Literature DB >> 24073667

A miniature ultrasound probe is useful in reducing rebleeding after endoscopic cyanoacrylate injection for hemorrhagic gastric varices.

Szu-Chia Liao1, Sheng-Shun Yang, Chun-Wang Ko, Han-Chung Lien, Chun-Fang Tung, Yen-Chun Peng, Hong-Zen Yeh, Chi-Sen Chang.   

Abstract

OBJECTIVE: To better assess the usefulness of miniature ultrasound probe (MUP) sonography in the evaluation of the adequacy of gastric variceal injection with cyanoacrylate to decrease the risk of post injection rebleeding.
MATERIAL AND METHODS: Sixty-nine patients with bleeding gastric varices were included in this study. Endoscopic cyanoacrylate injection was performed in the acute phase for variceal hemostasis. After injection, patients (n = 34) included in the MUP group prospectively received endoscopic ultrasonography (EUS) with MUP during each scheduled endoscopic follow-up session. Patients (n = 35) in the control group who were included historically were followed up with the same interval with endoscopy only.
RESULTS: Four (11.4%) patients in the control group received reinjection, and there were 10 episodes of rebleeding in 7 (20.0%) patients. Nine (26.5%) patients received reinjection due to inadequate obturation as judged by EUS. There were six episodes of rebleeding in three (8.8%) patients in the MUP group. The free-of-rebleeding rate for the MUP group was significantly higher than that for the control group (p < 0.05). The cumulative survival for the MUP group was slightly better than that for the control group but was not statistically significant. The patients' compliance in both groups was similar. The endosonographers considered the performance of MUP sonography to be convenient.
CONCLUSIONS: MUP sonography is useful for the evaluation of the adequacy of tissue adhesive obturation of gastric varices that may reduce the probability of rebleeding.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24073667     DOI: 10.3109/00365521.2013.838995

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  7 in total

Review 1.  Endoscopic management of bleeding gastric varices--an updated overview.

Authors:  Dana Crisan; Marcel Tantau; Alina Tantau
Journal:  Curr Gastroenterol Rep       Date:  2014-10

Review 2.  Management of gastric variceal bleeding: Role of endoscopy and endoscopic ultrasound.

Authors:  Mohit Girotra; Saikiran Raghavapuram; Rtika R Abraham; Mrinal Pahwa; Archna R Pahwa; Rayburn F Rego
Journal:  World J Hepatol       Date:  2014-03-27

Review 3.  The role of EUS in diagnosis and treatment of liver disorders.

Authors:  Sara Campos; Jan-Werner Poley; Lydi van Driel; Marco J Bruno
Journal:  Endosc Int Open       Date:  2019-10-01

4.  Comparative study for predictability of type 1 gastric variceal rebleeding after endoscopic variceal ligation: High-frequency intraluminal ultrasound study.

Authors:  Jeong Hwan Kim; Won Hyeok Choe; Sun-Young Lee; So Young Kwon; In-Kyung Sung; Hyung Seok Park
Journal:  World J Clin Cases       Date:  2021-12-06       Impact factor: 1.337

Review 5.  Safety, Efficacy, and Outcomes of N-Butyl Cyanoacrylate Glue Injection through the Endoscopic or Radiologic Route for Variceal Gastrointestinal Bleeding: A Systematic Review and Meta-Analysis.

Authors:  Olivier Chevallier; Kévin Guillen; Pierre-Olivier Comby; Thomas Mouillot; Nicolas Falvo; Marc Bardou; Marco Midulla; Ludwig-Serge Aho-Glélé; Romaric Loffroy
Journal:  J Clin Med       Date:  2021-05-25       Impact factor: 4.241

Review 6.  Utility of endoscopic ultrasound in the diagnosis and management of esophagogastric varices.

Authors:  An-Jiang Wang; Bi-Min Li; Xue-Lian Zheng; Xu Shu; Xuan Zhu
Journal:  Endosc Ultrasound       Date:  2016 Jul-Aug       Impact factor: 5.628

7.  Risk of rebleeding from gastroesophageal varices after initial treatment with cyanoacrylate; a systematic review and pooled analysis.

Authors:  Zixuan Hu; Decai Zhang; Joel Swai; Tao Liu; Shaojun Liu
Journal:  BMC Gastroenterol       Date:  2020-06-09       Impact factor: 3.067

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.